Serratiopeptidase is a multi-functional proteolytic enzymes that dissolves non-living tissues such as fibrin, plaque, blood clots, cysts and inflammation in all forms, without harming living tissue. It was originally isolated from the silkworm, which produces it to break down its hard cocoon walls.
A striking quality of serratiopeptidase is its profound ability to reduce pain by blocking the release of pain-inducing amines. It has received wide use as an analgesic in Europe, where it now outsells ibuprofen, brand-name painkillers and prescription Nsaids. Serratiopeptidase has no gastrointestinal side effects. It is an anti-inflammatory, anti-edemic (lessening of fluid retention) and dissolves protein build-up. It alters the elasticity and viscosity of the dense mucous produced in people with respiratory conditions. People with sinusitis, bronchitis, asthma and pulmonary diseases have shown much improved structure and function of the mucous after taking serratiopeptidase.
Serratiopeptidase has also been found to be effective against arthritis, ear, nose and throat conditions, injury-related swelling, varicose veins and other circulatory problems, and has been used to dissolve arterial plaque.
Serratiopeptidase should be taken as recommended by a Health Care Professional.